Clinical Trial Update: A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of escalating doses of GSK189075A in healthy volunteers and individual…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK189075A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED